PathwayOral Liquid Potassium Chloride Dosing Pathway in a Tertiary Care Veteran Affairs Academic Medical CenterBenge, Cassandra D. PharmD*; Burka, Abigail T. PharmD*,†Author Information From the *Veterans Affairs Tennessee Valley Healthcare System Pharmacy Services, Nashville, TN †Lipscomb University College of Pharmacy and Health Sciences, Nashville, TN. Received for publication July 30, 2019; accepted August 29, 2019. Reprints: Abigail T. Burka, PharmD, Department of Pharmacy Practice, 1 University Park Drive¸ Nashville, TN 37204. E-mail:firstname.lastname@example.org. Critical Pathways in Cardiology: March 2020 - Volume 19 - Issue 1 - p 18-21 doi: 10.1097/HPC.0000000000000197 Buy Metrics Abstract Hypokalemia, defined as a serum potassium (K+) concentration of <3.5 mEq/L, is an electrolyte imbalance commonly found in hospitalized patients. Hypokalemia is associated with potentially severe complications, including arrhythmias, which necessitate careful monitoring and repletion with potassium. In the inpatient setting, serum K+ may be repleted via intravenous or oral routes, with oral administration preferred. Potassium chloride (KCl) for oral administration is widely available in both immediate as well as an extended release formulations. Immediate release liquid KCl is optimal for inpatient use since it demonstrates rapid absorption and subsequent increase in serum K+ levels. However, acquisition costs for unit dose oral liquid KCl have prompted some institutions to implement guidance for appropriate use of KCl oral liquid. In this article, we describe the creation of a clinical pathway for ordering of oral immediate release KCl for inpatients at a tertiary Veterans Affairs Academic Medical Center. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.